This message was sent to ##Email##
Deadline: Tuesday, November 27, 2017 at 11:59 pm ET
The American Society for Nutrition (ASN) is pleased to announce the opening of abstract submission for Nutrition 2018, ASN’s inaugural flagship meeting, which will be held June 9-12, 2018 at the Hynes Convention Center in Boston, MA. ASN encourages the submission of original research in the form of abstracts for presentation. Take advantage of this opportunity to:
All abstracts will be reviewed and scored by 3-5 ASN members. With the exception of abstracts submitted for protocols and methods, all abstracts must include study results. Please note that omission of study results may result in a rejected abstract. To submit an abstract, please visit the Nutrition 2018 abstract submission website.
The deadline for abstract submissions is January 18, 2018.
- Share your research with the greatest minds in nutrition science
- Become eligible for travel awards and scholarships
- Network with peers in academia, industry and government
- Publish your work in Current Developments in Nutrition, ASN’s open-access journal
- Be a part of history!
The latest issue of FASEB’s Horizons in Bioscience publication, “Liquid Biopsies: A New Way to Diagnose, Understand & Track Cancer,” has just been released. This two-page resource describes a new technology developed to advance cancer treatment.
FASEB’s Horizons in Bioscience is a series of brief, illustrated articles that describe scientific discoveries on the brink of clinical application. The publication has explored CRISPR/Cas technology, organs-on-a-chip, and epigenetics, among other topics. Printed copies of the articles are available at no cost for educational or advocacy purposes and can be requested by visiting the Breakthroughs & Horizons in Bioscience webpage or by contacting FASEB’s Office of Public Affairs at 301-634-7650.
A new report from Research America shows that investment in medical health research and development (R&D) is on the rise, with a 20.6% growth in spending from 2013 to 2016.
The report, developed from data derived from industry sources; federal, state, and local governments; academic and research institutions; hospital research centers; and grant-giving entities, found that the total amount that the United States spent on medical and health R&D in 2016 reached $171.8 billion.
S100A4 amplifies TGF-β-induced epithelial–mesenchymal transition in a pleural mesothelial cell line
Qian Ning, Feiyan Li, Lei Wang, Hong Li, Yan Yao, Tinghua Hu, Zhongmin Sun
Journal of Investigative Medicine Nov 2017, jim-2017-000542; DOI:10.1136/jim-2017-000542
Cognitive enhancers associated with decreased risk of injury in patients with dementia: a nationwide cohort study in Taiwan
Pei-Chun Chao, Wu-Chien Chien, Chi-Hsiang Chung, Ching-Wen Chu, Chin-Bin Yeh, San-Yuan Huang, Ru-Band Lu, Hsin-An Chang, Yu-ChenKao, Hui-Wen Yeh, Wei-Shan Chiang, Yu-Ching Chou, Nian-ShengTzeng
Journal of Investigative Medicine Nov 2017, jim-2017-000595; DOI:10.1136/jim-2017-000595
Potential approaches to prevent hypoglycemia-associated autonomic failure
Eric Lontchi-Yimagou, Jee Young You, Michelle Carey, Ilan Gabriely, Harry Shamoon, Meredith Hawkins
Journal of Investigative Medicine Nov 2017, jim-2017-000582; DOI:10.1136/jim-2017-000582
miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2
Hongliang Diao, Zhou Ye, Renyi Qin
Journal of Investigative Medicine Nov 2017, jim-2017-000598; DOI:10.1136/jim-2017-000598
A new predictor of atrial fibrillation after coronary artery bypass graft surgery: HATCH score
Mithat Selvi, Hasan Gungor, Cemil Zencir, Sevil Gulasti, Ufuk Eryilmaz, Cagdas Akgullu, Selim Durmaz
Journal of Investigative Medicine Nov 2017, jim-2017-000525; DOI:10.1136/jim-2017-000525
Stay informed about JIM and register for e-alerts.
Disseminated Mycobacterium avium-Intracellulare Complex Infection Presenting With Disseminated Intravascular Coagulation in an AIDS Patient
Michael McPhaul, MD,
Disseminated Mycobacterium avium-intracellulare complex (MAC) infection is one of the relatively common opportunistic infections seen in severely immunocompromised AIDS patients. A constellation of clinical, laboratory, and pathological features involving multiple organ systems are often present in disseminated MAC infection but disseminated intravascular coagulation (DIC) has not been previously described in association with this condition. To our knowledge, this is the first reported case of DIC complicating disseminated MAC infection in an AIDS patient. In this article, we present the case of a 33-year-old AIDS patient with high viral load, CD4 lymphocyte count of 1/mm3, who presented with nonspecific symptoms, anemia, thrombocytopenia, and increased lactate dehydrogenase, alkaline phosphatase, and ferritin. She also had abnormal coagulation parameters and features compatible with chronic DIC. Bone marrow biopsy assisted in making the correct diagnosis. She also later grew MAC from blood and sputum cultures. There were no other factors identified after a complete workup to explain DIC in this patient. After commencement of appropriate MAC therapy, she initially had a good response with some improvement of her coagulation parameters. Few months later, however, probably attributable to poor medication compliance, her condition deteriorated with development of thromboembolism, full-fledged DIC, sepsis, and an eventual fatal outcome. This case illustrates the importance of including disseminated MAC in the differential diagnosis of DIC in an AIDS patient. READ MORE
Inflammatory Breast Cancer and Warm Antibody Autoimmune Hemolytic Anemia: A Rare Paraneoplastic Syndrome
Autoimmune hemolytic anemia (AIHA) is a disease process that involves the destruction of red blood cells mediated by the humoral immune system. It can be characterized as a cold agglutinin syndrome, paroxysmal cold hemoglobinuria, and warm, mixed type, and drug-induced AIHA. Although a well-established relationship exists between the presence of AIHA and lymphoproliferative malignancy, AIHA rarely presents in association with solid malignancies. An analysis of the limited number of published cases of AIHA in association with solid malignancies performed showed that AIHA may present before the diagnosis of a solid malignancy, concurrently with the presence of a solid malignancy, or even on resolution of a solid malignancy. Few cases of solid cancers associated with AIHA have been reported. AIHA rarely presents as a paraneoplastic syndrome indicating existence of a solid cancer. We report a case of inflammatory breast cancer with AIHA. READ MORE
Gastric Pouch Mixed Adenoneuroendocrine Carcinoma With a Mixed Adenocarcinoma Component After Roux-en-Y Gastric Bypass
The Roux-en-Y gastric bypass is one of the most common procedures currently performed for surgical treatment of patients with severe obesity. Gastric cancer after bariatric surgery is not common, with most of them arising in the excluded stomach. Gastric mixed adenoneuroendocrine carcinomas are a rare type of stomach malignancy, composed of both adenocarcinoma and neuroendocrine tumor-cell components, with the latter comprising at least 30% of the whole neoplasm. In this article, we report a unique case of a mixed adenoneuroendocrine carcinoma with a mixed adenocarcinoma (tubular and poorly cohesive) component arising in the gastric pouch of a patient who underwent previous Roux-en-Y gastric bypass for glycemic control. Since stomach cancer is not usual in patients who have formerly undergone bariatric surgery and symptoms tend to be nonspecific, such diagnosis is often rendered at an advanced stage. Full assessment of these patients when presenting such vague symptoms is critical for an early cancer diagnosis. READ MORE
Use of Phenobarbital in Delirium Tremens
The standard of care for alcohol withdrawal centers on the use of escalating doses of benzodiazepines until clinical improvement is achieved. However, there is no established standard in the care of patients with severe alcohol withdrawal and delirium tremens that is refractory to benzodiazepine therapy. One potential therapy that is gaining traction is the use of phenobarbital, which may be mechanistically superior to benzodiazepines in treating delirium tremens because of its effects on GABA and N-methyl-D-aspartate receptors. The dosing of phenobarbital and its subsequent taper, however, is still unclear and the side effect profile is not well characterized. In this case report, we present the case of a 37-year-old Hispanic male who presented with alcohol withdrawal and subsequent delirium tremens who was treated with phenobarbital with positive clinical response and minimal side effects. READ MORE
Stay informed about JIM-HICR and register for e-alerts.
Researchers from the National Institutes of Health and the University of Chicago improved the speed, resolution, and light efficiency of an optical microscope by switching from a conventional glass coverslip to a reflective, mirrored coverslip and applying new computer algorithms to process the resulting data.
Hari Shroff, Ph.D., chief of the National Institute of Biomedical Imaging and Bioengineering’s lab section on High Resolution Optical Imaging (HROI), and his team have spent the last few years developing optical microscopes that produce high resolution images at very high speed.
New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist Ray Dorsey, M.D. and Bastiaan Bloem, M.D., Ph.D., with Radboud University Medical Center in the Netherlands, argue that the medical community must be mobilized to respond to this impending public health threat.
A team from the NUS Yong Loo Lin School of Medicine (NUS Medicine) has invented a fundamentally new way of folding and protecting recombinant proteins. Sourced from the rapidly expanding field of synthetic biology, this protein-in-a-protein technology can improve functional protein yields by 100-fold and protect recombinant proteins from heat, harsh chemicals and proteolysis.
Thirty years ago, scientists began to unlock the mysteries regarding the cause of Alzheimer's disease. This knowledge ushered in an era of great enthusiasm that scientists could develop new therapies to either prevent Alzheimer's or significantly slow the symptoms once present. Despite continued progress and renewed hope that some therapies now in human trials will modify the course of the disease, the initial optimism of neuroscientists like me has been significantly tempered by reality.
Current guidelines recommend a systolic blood pressure treatment target below 140 mm Hg for most people. Since the publication of SPRINT however, many have suggested guidelines should be changed, recommending further blood pressure lowering.
We performed a systematic review and meta-analysis of randomized clinical trials comparing different blood pressure targets or antihypertensive treatment verus placebo.
|January 25-27, 2018
||Western Medical Research Conference
|February 22-24, 2018
||Southern Regional Meeting
||New Orleans, LA
|March 16, 2018
||Eastern Regional Meeting
|April 19-21, 2018
||Translational Science 2018
|April 21-25, 2018
|| Experimental Biology 2018
||San Diego, CA
|April 26-27, 2018
||2018 Combined Annual Meeting of CSCTR & MWAFMR
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Thomas, Assistant Executive Editor, 469-420-2635 | Contribute news
MingMing Ning, AFMR Chair, Publishing Committee, 978-927-8330 | www.afmr.org
Elissa Klein, AFMR Executive Director, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4400 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063